mechanism 2,240 words KG: ent-gene-961a77ee
Contents

APP-BACE1-Fe65 Complex

🔬 Protein Info
Gene SymbolAPP
Full NameBACE1-Fe65 Complex
Chromosome21q21.3
Protein TypeProtein
Functionis a type I transmembrane glycoprotein that plays a central role in the pathogenesis of Alzheimer's disease (AD).
Primary ExpressionUbiquitous, highest in brain
Subcellular Localizationof APP processing is critical—BACE1 activity is highest in lipid rafts, specialized membrane microdomains rich in choles
Molecular Weight~110 kDa
Exons18
PathwaysAmyloid, Angiogenesis, Apoptosis, Autophagy, Blood-Brain Barrier
UniProt IDP05067
NCBI Gene ID351
Ensembl IDENSG00000142192
OMIM104760
GeneCardsAPP
Human Protein AtlasAPP
Associated DiseasesAD, aging, Als, Alzheimer
Known Drugs/CompoundsAbeta, aducanumab, Atractylodes macrocephala, berberine, BERBERINE, D-520
InteractionsA2M, ABCA1, ABCA7, ACETYLCHOLINE, ACHE, ACSL4
SciDEX HypothesesSelective Cholinergic Protection via APP Pathway M
KG Connections4392 knowledge graph edges
DatabasesGeneCardsHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (11)

Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (24)

Plasma ATN biomarkers across AD continuum in Chilean cohort
clinical · proposed · Score: 0.95
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's diseas
validation · proposed · Score: 0.95
Anti-ASC antibody intracerebroventricular injection in APP/P
validation · proposed · Score: 0.95

Knowledge Graph (12 edges)

ent-gene-961a77ee has_risk_variant multiple
ent-gene-961a77ee participates_in_pathway R-HSA-933542
ent-gene-961a77ee participates_in_pathway R-HSA-879415
ent-gene-961a77ee participates_in_pathway R-HSA-977225
ent-gene-961a77ee participates_in_pathway R-HSA-9936686
ent-gene-961a77ee participates_in_pathway R-HSA-9936900
ent-gene-961a77ee participates_in_pathway R-HSA-3000178
ent-gene-961a77ee participates_in_pathway R-HSA-8862803
ent-gene-961a77ee participates_in_pathway R-HSA-9660826
ent-gene-961a77ee participates_in_pathway R-HSA-844456

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.